Cere®Screen Digital Display Label
Product Gallery
Information
The Cere®Screen digital display label seamlessly integrates digital screens into clinical trial investigational medicinal product packaging, ushering in a new era of investigational medicinal product labeling. It provides real-time, programmable, digital labeling. The screen allows for multiple pages and contains all required label content, including QR codes and other information. A push button enables users to scroll through the pages. Cere®Screen digital display labels can be customized to suit the specific needs of the trial, including support for multiple languages. The information can be digitally updated using an authorized cellular connection or PC-based controls, depending on the established protocol. This enables clinical trial investigators to securely update expiry date, dosage information, warnings, or instructions in real time.
Country
United States of America
Product Type
Secondary Packaging
Application Areas
The conventional clinical trial relabeling process is burdened with labor-intensive tasks, consumes valuable time, and prone to unique challenges. When clinical trial investigational medicinal products (IMP) need to be updated, the entire process can demand painstaking relabeling efforts. This often entails creating new labels, orchestrating coordination among multiple stakeholders, and meticulously documenting & managing each step. The Cere®Screen digital display label seamlessly integrates digital screens into clinical trial investigational medicinal product packaging, ushering in a new era of investigational medicinal product labeling.
Key Features
The Cere®Screen digital display label is designed to benefit clinical trial supply and patients by providing digital functionality, customization, and remote updates. The Cere®Screen allows for multiple pages, accommodating all required label content, including QR and bar codes. A simple push button lets users scroll through the pages effortlessly. Cere®Screen Digital Display Labels can be late stage customized to suit the specific needs of your trial, whether it’s multilingual support or trial-specific information. Researchers can remotely and securely update label content in real time, updating expiry dates, information, warnings, or instructions seamlessly using an authorized cellular connection or PC-based controls, depending on the protocol established. These features collectively have the potential to enhance the efficiency, flexibility, and responsiveness of the clinical trial supply chain, ultimately ensuring that stakeholders receive the most up-to-date and accurate information when and where they need it.
